Search
By Biotech Mag - 1 day ago
PRINCIPAL RESEARCH SCIENTIST - ELI LILLY - SAN DIEGO, CA
This experienced senior scientist research position resides at the Lilly Biotechnology Center-San Diego in the department of Biotechnology...
By Biotech Mag Top - 3 days ago
BIO ROUNDUP: ELI LILLY TRIES TAU, GENERIC INSULIN, NASH CASH & MORE
Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used...
Pharmaceutical, Pharmaceuticals, Manufacturing, Drugs, Discovery, Drug, Industrial, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, AC Immune, Addiction, AGTC, Akero Therapeutics, Alex Denner, AMAG Pharmaceuticals, Aro Biotherapeutics, atezolizumab, Bausch Health, bevacizumab, Biogen, Biotech, Black Diamond Therapeutics, Breast Cancer, cancer, cancer immunotherapy, CAR-T, Celgene, Cell Therapy, Chemotherapy, ciraparantag, Clive Meanwell, CRISPR, Daniel O'Day, deals, diabetes, Dragonfly Therapeutics, drug prices, Eli Lilly, FDA, ganaxolone, generic drugs, Gilead Sciences, guselkumab, Hepatitis C, Insulin, Intra-Cellular Therapies, investing, IPO, Johnson & Johnson, Kaleo, Kite Pharma, Lewy Body Dementia, Life Sciences, life sciences biotech, lumateperone, Marinus Pharmaceuticals, Mark Timney, Mission Bio, ModeRNA, nelotanserin, Neurocrine Biosciences, Non-Small Cell Lung Cancer, nonalcoholic steatohepatitis, Novartis, opioid, opioid abuse, patent, Pear Therapeutics, Perosphere Pharmaceuticals, postpartum depression, Sage Therapeutics, Schizophrenia, Scott Gottlieb, secukinumab, startups, Synergy Pharmaceuticals, The Medicines Co., Timothy Springer, Tourette syndrome, Tyler Jacks, University of Toronto, valbenazine, Venture Capital, Versant Ventures, X-linked retinoschisis
More
By Biotech Mag - 5 days ago
ELI LILLY PARTNERS WITH AC IMMUNE ON TAU BLOCKERS FOR ALZHEIMER'S
There's at least one major pharmaceutical company that isn't giving up yet on finding an Alzheimer's disease drug. Eli Lilly is pairing...
Protein, Pharmaceutical, Pharmaceuticals, Immunity, Drugs, Drug, Boston blog main, Boston top stories, Indiana, Indiana blog main, Indiana top stories, National blog main, AC Immune, Alzheimer's, Alzheimer's disease, amyloid, beta-amyloid, Biogen, Biotech, deals, Eisai, Eisai Pharmaceuticals, Eli Lilly, Life Sciences, Partnership, Tau
More
By Cars Mag - 7 days ago
JAY LENO HIGHLIGHTS HIS DELIGHTFUL 1958 SAAB 93
Jay Leno's Garage is a varied place. In the garage, you'll find modern marvels like a 2017 Ford GT, uber-rare supercars like the McLaren...
By News Times - 7 days ago
BARKLEY RUSHES FOR 170 YARDS, GIANTS ROUT REDSKINS 40-16
LANDOVER, Md. - Saquon Barkley rushed for 170 yards, including a 78-yard touchdown to surpass 1,000 for the season, Eli Manning threw...
By Music Mag - 8 days ago
HOW DO RAINBOWS FORM? WELL, PRIYANKA CHOPRA WALKS INTO A ROOM WEARING THIS DRESS
Priyanka Chopra was shining and shimmering at a Bumble launch party in Mumbai on Dec. 7, and not just because of her newlywed glow....
By Biotech Mag Top - 27 days ago
LILLY CMO ROBERT BROWN TO LEAD BRICKELL BIO AS IT EYES PHASE 3 DERMATOLOGY TRIALS
Eli Lilly VP Robert Brown is making the jump to serve as CEO of the skin disease-focused Brickell Biotech, as it prepares to move its...
By Biotech Mag - 1 month ago
BIO ROUNDUP: MODERNA'S IPO, ARENA'S COMEBACK, E-CIG SURVEY & MORE
Thanksgiving is around the corner and this week delivered a bounty of deals that have a number of life science companies expressing...
Life Science, BioTech, Biotech, Science, Clinical, Drug, Drugs, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, Aimmune Therapeutics, alopecia areata, Amarin, Arena Pharmaceuticals, avapritinib, Blueprint Medicines, Boehringer Ingelheim, Cadent Therapeutics, cancer, cancer immunotherapy, Celgene, Centers for Disease Control and Prevention, Centrexion Therapeutics, clinical trials, CoLucid Pharmaceuticals, Concert Pharmaceuticals, Dragonfly Therapeutics, Eli Lilly, Esophageal cancer, FDA, galcanezumab, Gene Therapy, Harpoon Therapeutics, hemophilia, Kymera Therapeutics, Lasmiditan, Life Sciences, Matt Kapusta, medicare, Merck, Migraine, ModeRNA, Nektar Therapeutics, Nestle Health Sciences, NextCure, Nivolumab, pembrolizumab, Pfizer, protein degradation, ralinepag, Renaissance Capital, Ribometrix, RNA, Roivant Sciences, Scott Gottleib, Spark Therapeutics, Synthorx, uniQure, United Therapeutics, Vivek Ramaswamy
More
By Biotech Mag Top - 1 month ago
SYNTHORX FILES FOR IPO TO ADVANCE ENHANCED CYTOKINE DRUGS
Synthetic biology company Synthorx is laying plans for an initial public offering to raise money to advance its suite of enhanced cytokine...
Therapies, NASDAQ, Biology, Biologic, Biological, Cancer, Drug, Applied, Drugs, Boston blog main, National blog main, National top stories, New York blog main, San Diego, San Diego blog main, San Diego top stories, San Francisco blog main, Armo Biosciences, Autoimmune, Avalon Ventures, Biotech, cancer, COI Pharmaceuticals, Correlation Ventures, Crohn's Disease, cytokines, deals, Drug Development, Eli Lilly, fundraising, GVHD, immune checkpoint, innovation, IPO, Jay Lichter, Joseph Leveque, Laura Shawver, Life Sciences, Medicxi, Orbimed, Osage, RA Capital Management, S-1, solid tumor cancer, startups, Synthorx, VC, Venture Capital
More
By Biotech Mag Top - 1 month ago
BIO ROUNDUP: MIDTERM FALLOUT, ALZHEIMER'S SEARCH, POSTPARTUM PANEL
There was plenty at stake in this week's midterm elections, and not just in terms of political wins and losses. With congress now divided-Democrats...
Healthcare, Drug, Drugs, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, Abeona Therapeutics, Achaogen, Affordable Care Act, Alnylam Pharmaceuticals, Alzheimer's, Amgen, AstraZeneca, Biosimilar, brexanolone, celiac disease, Chris Collins, clinical trials, Coherus Biosciences, Cydan Development, deals, EGFR, Eli Lilly, FDA, Foamix Pharmaceuticals, Gene Therapy, GOP, Johnson & Johnson, lazertinib, Life Sciences, Lung Cancer, Mallinckrodt, Medicaid, medicare, MEI Pharma, Merrimack Pharmaceuticals, midterm elections, Neulasta, NextCure, Novartis, Parkinson's Disease, postpartum depression, RegenxBio, Regulus Therapeutics, RNA Interference, Sanofi, Spinal Muscular Atrophy, startups, Sucampo Pharmaceuticals, Tagrisso, Voyager Therapeutics, Yuhan
More
By Biotech Mag Top - 1 month ago
FDA APPROVES ELANCO CATTLE DRUG, THE FIRST FOR REDUCING GAS EMISSIONS
A product that reduces emissions from farm animal waste? There's now a drug for that. The FDA has approved an Elanco drug developed...
Gas, Agricultural, Agriculture, Environmental, Animals, Drug, Drugs, Indiana, Indiana blog main, Indiana top stories, National blog main, AgtechFood, algae, ammonia, Biotech, cleantech, Elanco, Eli Lilly, Environmental Protection Agency, FDA, FDA Center for Veterinary Medicine, Food and Drug Administration, Life Sciences, lubabegron, Steven Solomon
More
By Sportyst Usa - 1 month ago
MANNING WANTS TO REMAIN THE GIANTS STARTING QUARTERBACK
Two-time Super Bowl MVP Eli Manning isn't ready to hand over the job as the New York Giants starting quarterback
By VIP Net - 1 month ago
WHAT DOES THE FUTURE OF BRIDAL AND WEDDING MEDIA LOOK LIKE?
"I would contend that 2018 has been the biggest year of change in wedding media in the last 10 years, bar none," says veteran wedding...
By Biotech Mag Top - 1 month ago
BIO ROUNDUP: ALZHEIMER'S PUZZLE, ESMO ASSESSED, DRUG PRICES & MORE
In the biotech investment and research communities this week, much of the attention was turned to Europe. Munich, Germany, hosted the...
Research, Genetics, BioTech, Biotech, Pharmaceutical, Cancer, Clinical, Drug, Drugs, Pharmaceuticals, Europe, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, 89Bio, AbbVie, Adrian Krainer, Alexion Pharmaceuticals, Alzheimer Europe Conference, Alzheimer's disease, AstraZeneca, Bain Capital, Biogen, Biotech IPOs, Bristol-myers Squibb, cancer, cancer immunotherapy, Cerevel Therapeutics, clinical trials, Convergence Pharmaceuticals, CRISPR Therapeutics, Cystic Fibrosis, Dicerna Pharmaceuticals, Ed Kaye, Eisai, Eli Lilly, European Society for Medical Oncology, FDA, Galapagos NV, Genoptix, Innate Pharma, Innovent Biologics, investing, Life Sciences, Matt Porteus, medicare, Mirati Therapeutics, NeoGenomics, Nivolumab, nonalcoholic steatohepatitis, OrbiMed Advisors, Osteoarthritis, pain drug, Pfizer, Phrma, President Trump, Qpex Biopharma, Regeneron Pharmaceuticals, Sam Isaly, Sarepta Therapeutics, Spinal Muscular Atrophy, Spinraza, SpringWorks Therapeutics, Stanford University, startups, Stoke Therapeutics, Synthego, Teva Pharmaceutical, The Medicines Company, UCB, Vertex Pharmaceuticals
More
By Ladies Mag - 1 month ago
GOLDEN HOURELIE SAAB READY-TO-WEAR AUTUMN WINTER 2018-19
Golden Hour ELIE SAAB Ready-to-Wear Autumn Winter 2018-19 accessory collection
By Biotech Mag Top - 1 month ago
BAUBLES & BLING: SWOONERY USES TECH TO CONNECT SHOPPERS WITH JEWELRY
Jean Poh's family has been in the jewelry business for four generations. And, for the most part, the industry has operated much the...
Industrial, Boston blog main, Boulder, Denver blog main, Denver top stories, Detroit blog main, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Texas top stories, Wisconsin blog main, Akillis, Calvin Klein, Carmen Busquets, e-commerce, e-retail, Elie Top, funding, innovation, Jean Poh, jewelry, Net-a-Porter, new york, people, robotics, AI, sap, startups, Swoonery, VanLeles, Visual Search, xperience
More
By Sportyst Usa - 1 month ago
ELI APPLE SHOULD BE JUST THE START OF TORCHING THESE GIANTS
As the Giants burn, let the fire sale begin. Tuesday's trade of Eli Apple to the Saints for a 2019 fourth-round pick and a 2020 seventh-rounder...
Pages
We are sorry, there is no page for your query.